Results 81 to 90 of about 4,185 (125)

The Management of Cytokine Storm in COVID-19

open access: yesActa Medica Indonesiana, 2020
Cytokine storm in COVID-19 infection is an excessive immune response to external stimuli where the pathogenesis is complex. The disease progresses rapidly and the mortality is high.
Cleopas Martin Rumende   +2 more
doaj   +2 more sources

Bioactive Molecules from Tropical American Plants: Potential Anti-Inflammatory Agents for Cytokine Storm Management

open access: yesMolecules
The cytokine storm, a hyperinflammatory response characterized by the excessive release of pro-inflammatory mediators such as TNFα, INFγ, IL-1β, IL-6, and GM-CSF, has been identified as a critical factor in the progression and severity of acute ...
Erika Plazas   +2 more
doaj   +1 more source

A Dual‐Membrane Biomimetic Nanoplatform Enables Triple‐Modal Therapy Against SARS‐CoV‐2 Through Viral Decoy, Inflammation Neutralizing, and Intracellular RNAi

open access: yesAdvanced Science, Volume 13, Issue 64, 16 November 2026.
[A&T]MLN is a triple‐modal nanoplatform with siRNA‐loaded LN coated with hybrid ACE2/macrophage membrane. It blocks viral entry, neutralizes IL‐6/IL‐1β/TNF‐α, and delivers siRNA to suppress viral replication. In a murine lung injury model, it attenuates inflammation, offering a multi‐pronged strategy against SARS‐CoV‐2 variants and hyperinflammation ...
Hui Li   +19 more
wiley   +1 more source

Hyper-inflammation and immunosuppression: redefining sepsis therapy using modern approaches

open access: yesFrontiers in Pharmacology
BackgroundSepsis is a life-threatening condition characterized by simultaneous hyperinflammation and immunosuppression, which leads to organ dysfunction and mortality.
Mili Prajapati   +5 more
doaj   +1 more source

Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis in a Child With Coronary Artery Dilation and SARS‐CoV‐2 Positivity: Diagnostic Overlap With MIS‐C. A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Macrophage activation syndrome (MAS) can complicate systemic juvenile idiopathic arthritis (sJIA) evolving over weeks. With SARS‐CoV‐2 positivity and coronary dilation, MIS‐C cannot be excluded, and here the timeline and serology do not establish SARS‐CoV‐2 as the trigger.
Ayham Slimi   +3 more
wiley   +1 more source

Effect of Tocilizumab Treatment on Seroconversion in Hyperinflammation Secondary to Covid 19 [PDF]

open access: yes
Aim:During the ongoing COVID-19 pandemic, the management of hyperinflammation, a serious symptom that occurs secondary to the disease, has emerged as a major challenge. Tocilizumab, an immunosuppressive drug, offers a potential solution.
Faruk Karandere   +11 more
core   +2 more sources

Dengue Virus Pathogenesis: Innate Immune Signaling and Cell Death Receptor Pathways

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 11, November 2026.
ABSTRACT Background The infection caused by the dengue virus (DENV) involves a complicated interaction between viral replication and the body's immune responses. As the first line of defense, the innate immune response limits viral replication but can also lead to immunopathology if it is improperly regulated.
Farjana Islam
wiley   +1 more source

Case Report: Late-onset primary hemophagocytic lymphohistiocytosis leading to the diagnosis of Griscelli syndrome type 2 in a young woman with phenotypically inapparent partial albinism

open access: yesFrontiers in Immunology
Griscelli syndrome type 2 (GS-2) is a rare congenital immune dysfunction characterized by partial albinism and recurrent episodes of hemophagocytic lymphohistiocytosis (HLH).
Johanna Rausch   +28 more
doaj   +1 more source

Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids

open access: yesJournal of Medical Virology, Volume 98, Issue 11, November 2026.
ABSTRACT We aimed to evaluate the association between IL10 variants and plasma IL‐10 levels and clinical outcomes in patients with severe COVID‐19 treated with corticosteroids. We studied 944 patients with severe COVID‐19 who were treated with corticosteroids.
Ingrid Fricke‐Galindo   +12 more
wiley   +1 more source

Primary splenic diffuse large B-cell lymphoma masquerading as systemic lupus erythematosus: a case report

open access: yesFrontiers in Medicine
BackgroundDiffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma, whereas primary splenic DLBCL (PS-DLBCL) is exceedingly rare.
Zhaoxia He   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy